Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
2.250
-0.200 (-8.16%)
Sep 4, 2026, 11:01 AM EDT - Market open
Silo Pharma Market Cap
Silo Pharma has a market cap or net worth of $3.57 million as of September 4, 2026. Its market cap has decreased by -39.43% in one year.
Market Cap
3.57M
Enterprise Value
-1.65M
1-Year Change
-39.43%
Ranking
Category
Stock Price
$2.25
ChartMarket Cap Chart
Since September 27, 2022, Silo Pharma's market cap has decreased from $13.10M to $3.57M, a decrease of -72.72%. That is a compound annual growth rate of -28.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.57M | -20.59% |
| Dec 31, 2025 | 4.50M | 12.50% |
| Dec 31, 2024 | 4.00M | -11.11% |
| Dec 29, 2023 | 4.50M | -57.14% |
| Dec 30, 2022 | 10.50M | -19.85% |
| Sep 27, 2022 | 13.10M | - |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 4.38M |
| Aptevo Therapeutics | 4.32M |
| GRI Bio | 4.32M |
| Alaunos Therapeutics | 4.32M |
| PMGC Holdings | 4.15M |
| Mustang Bio | 4.10M |
| VivoSim Labs | 4.08M |
| Revelation Biosciences | 4.06M |